Skip to main content
Equibles

Ikarian Capital, LLC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 1778253 DALLAS, TX
Back to PMVP Full portfolio

Position in PMVP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$119,442
+$8,914 QoQ
Shares Held
89,136
0.0% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 64 holders
Holding Since
Mar 2022
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMVP Over Time

Shares Held

Position Value (USD)

Derivatives in PMVP

reported options exposure · as of Mar 31, 2022
CallValue
$2,082,000
CallShares
100,000
PutValue
$2,082,000
PutShares
100,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. PMVP ranks #98 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in PMVP

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $119,442 89,136
2026-03-31 $110,528 89,136
2025-12-31 $111,420 89,136
2025-09-30 $136,500 97,500
2022-03-31 $2,082,000 100,000
2022-03-31 $2,082,000 100,000